PUMA BIOTECHNOLOGY (PBYI) stock: insider trades, news & valuation
Heavy sellingShare price and insider trades
PUMA BIOTECHNOLOGY insider trading at a glance (Oct 9, 2026): in the past 12 months, 0 insiders bought $0 and 10 sold $2.1M of PBYI stock on the open market.
Get emailed when insiders cluster-buy stocks like PBYI
Free alerts the day a new cluster buy is filed, plus the Monday report of the week's biggest insider trades.
Free · unsubscribe anytime · not investment advice · see a sample issue
PBYI insider buying and selling by quarter
Open-market purchases (green, above the line) and sales (red, below), by trade date.
| Quarter | Bought | Purchases | Sold | Sales |
|---|---|---|---|---|
| Q4 2026 | — | 0 | — | 0 |
| Q3 2026 | — | 0 | $1.1M | 5 |
| Q2 2026 | — | 0 | $573K | 5 |
| Q1 2026 | — | 0 | $322K | 6 |
| Q4 2025 | — | 0 | $97K | 1 |
Valuation, profit and volume
Summary
Over the past 12 months, 0 PUMA BIOTECHNOLOGY, INC. insiders reported open-market purchases totaling $0, while 10 insiders reported sales totaling $2.1M. 16 of 17 recorded sales were made under pre-scheduled Rule 10b5-1 trading plans, which are usually less informative than discretionary sales.
Insider transactions
Open-market purchases and sales.
| Filed | Insider | Type | Shares | Price | Value | Since | Score |
|---|---|---|---|---|---|---|---|
| Sep 16SEC | Alessandra CesanoDirector | Sell Plan | 62,15056,700 held (−52%) | $9.12 | $567K | +12.8% | — |
| Sep 16SEC | Troy Edward WilsonDirector | Sell Plan | 5,00054,750 held (−8%) | $9.10 | $46K | +13.1% | — |
| Jul 8SEC | Alan H AuerbachCEO, President | Sell Plan | 44,0587,261,671 held (−1%) | $8.26 | $364K | +24.6% | — |
| Jul 8SEC | Maximo F NouguesCFO | Sell Plan | 9,386230,637 held (−4%) | $8.26 | $78K | +24.6% | — |
| Jul 8SEC | Douglas M HuntSee Remarks | Sell Plan | 8,460196,841 held (−4%) | $8.26 | $70K | +24.6% | — |
| Jun 15SEC | Adrian SenderowiczDirector | Sell Plan | 27,00027,000 held (−50%) | $7.20 | $194K | +42.9% | — |
| Jun 15SEC | Jay M MoyesDirector | Sell Plan | 22,00058,322 held (−27%) | $7.22 | $159K | +42.5% | — |
| Jun 15SEC | Allison DorvalDirector | Sell Plan | 11,61090,780 held (−11%) | $7.20 | $84K | +42.9% | — |
| Jun 15SEC | Troy Edward WilsonDirector | Sell Plan | 10,80059,750 held (−15%) | $7.20 | $78K | +42.9% | — |
| Jun 15SEC | Brian M StuglikDirector | Sell Plan | 8,100113,858 held (−7%) | $7.20 | $58K | +42.9% | — |
| Jan 8SEC | Alan H AuerbachCEO, President | Sell Plan | 18,0127,145,951 held (−0%) | $5.88 | $106K | +75.0% | — |
| Jan 8SEC | Alan H AuerbachCEO, President | Sell Plan | 16,9387,163,963 held (−0%) | $5.84 | $99K | +76.2% | — |
| Jan 8SEC | Maximo F NouguesCFO | Sell Plan | 6,405193,284 held (−3%) | $5.88 | $38K | +75.0% | — |
| Jan 8SEC | Douglas M HuntSee Remarks | Sell Plan | 5,014155,907 held (−3%) | $5.88 | $29K | +75.0% | — |
| Jan 8SEC | Maximo F NouguesCFO | Sell Plan | 4,540199,689 held (−2%) | $5.84 | $27K | +76.2% | — |
| Jan 8SEC | Douglas M HuntSee Remarks | Sell Plan | 3,973160,921 held (−2%) | $5.84 | $23K | +76.2% | — |
| Nov 13SEC | Michael Patrick MillerDirector | Sell | 20,00054,000 held (−27%) | $4.86 | $97K | +111.7% | — |
Insiders at PUMA BIOTECHNOLOGY, INC.
| Insider | Bought | Sold | Last filing | Score |
|---|---|---|---|---|
| Alan H AuerbachCEO, President | — | $569K | Jul 8, 2026 | — |
| Alessandra CesanoDirector | — | $567K | Sep 16, 2026 | — |
| Adrian SenderowiczDirector | — | $194K | Jun 15, 2026 | — |
| Jay M MoyesDirector | — | $159K | Jun 15, 2026 | — |
| Maximo F NouguesCFO | — | $142K | Jul 8, 2026 | — |
| Troy Edward WilsonDirector | — | $123K | Sep 16, 2026 | — |
| Douglas M HuntSee Remarks | — | $123K | Jul 8, 2026 | — |
| Michael Patrick MillerDirector | — | $97K | Nov 13, 2025 | — |
| Allison DorvalDirector | — | $84K | Jun 15, 2026 | — |
| Brian M StuglikDirector | — | $58K | Jun 15, 2026 | — |
PBYI stock: common questions
Are PUMA BIOTECHNOLOGY, INC. insiders buying PBYI stock?
In the past 12 months, 0 insiders reported open-market purchases of PBYI worth $0.
Are PUMA BIOTECHNOLOGY, INC. insiders selling PBYI stock?
10 insiders reported sales worth $2.1M over the same period.
Where does this data come from?
Every transaction comes from Form 4 filings that insiders must submit to the SEC within two business days of a trade. We pull them from SEC EDGAR every night.
What is PBYI's 52-week range?
Over the past year PBYI has traded between $4.73 and $10.29. It last closed at $10.29 on Oct 9, 2026.